Welcome

PharmaSea brings together a broad international, interdisciplinary consortium of 24 partners from 13 countries from industry, academia and non-profit organisations with world-leading researchers in the areas of marine genomics, biosynthesis and chemical structure analysis as well as legal experts. The PharmaSea project focuses on biodiscovery research and the development and commercialisation of new substances from marine organisms. Its primary goal is to collect samples from some of the hottest, deepest and coldest places on the planet. These samples will be screened to uncover marine microbes and new bioactive compounds to evaluate their potential as novel drug leads, antibiotics or ingredients for nutrition or cosmetic applications. PharmaSea is funded by the European Union under its FP7 programme.

News

  • Pharma demands: fight superbugs now

    Pharma demands: fight superbugs now

    18.01.2016 - Stop squandering antibiotics and make research profitable again: at the World Economic Forum in Swiss Davos, 83 pharmaceutical companies have called for a unified approach towards the threat of antimicrobial resistance. More

  • PharmaSea congratulates Nobel Prize winners

    PharmaSea congratulates Nobel Prize winners

    18.10.2015 - PharmaSea, a project that focuses development of new substances from marine organisms, congratulates three scientists, who were awarded the 2015 Nobel Prize on Medicine this year for the discovery of novel natural products that became impactful therapies for infections by roundworm parasites and malaria. More

  • PharmaSea researcher Marla Trindade wins science award

    PharmaSea researcher Marla Trindade wins science award

    27.08.2015 - Prof. Marla Trindade has won the DST Distinguished Young Woman Researcher Award for her multidisciplinary work, aiming to develop biotechnologies from bacteria and their associated viruses, to benefit industries in the health. More

Executive Committee

Institutions

Calendar

All events